Plain-English translation of NCT07469319 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether offering regular screening for liver cancer — using ultrasound scans and a blood test — can help catch the disease earlier in people with cirrhosis (scarring of the liver) who don't have viral hepatitis. Right now, this screening is only recommended in Denmark for people whose cirrhosis was caused by hepatitis B or C. This trial will see if screening helps people with other types of cirrhosis too.
Liver cancer is a serious disease that often develops in people with cirrhosis, and it's much easier to treat when caught early. However, doctors aren't sure if regular screening actually saves lives in people whose cirrhosis wasn't caused by viral hepatitis, so this study is designed to find out.
You likely qualify if…
You likely don't qualify if…
If you join, you'll come in three times over one year (at the start, 6 months, and 12 months) for an abdominal ultrasound and a blood test. The ultrasound takes pictures of your liver to look for any signs of cancer, and the blood test measures a protein that can indicate liver cancer. If anything suspicious is found, you'll be offered standard follow-up testing to confirm whether you have liver cancer.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Denmark